Avid upgrades manufacturing facility
Avid Bioservices quality vice president Jeff Masten said the rollout of recent facility enhancements, as well as the plans for the next phases, requires timely, accurate and strategic
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.